Autologous Skin Fibroblasts (Johns Hopkins University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAutologous Skin Fibroblasts (Johns Hopkins University)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsWounds and Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University

China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins University

Inactive CompaniesN/A

Active IndicationsWounds and Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A